TOKYO (Reuters) – Japan has approved GlaxoSmithKline and Vir Biotechnology’s Sotrovimab as an antibody treatment for coronavirus, Health Minister Norihisa Tamura said on Monday.
The antibody treatment is for mild to moderate COVID-19 cases which do not require oxygen supplementation, GSK said when it applied for fast-track approval this month.
(Reporting by Makiko Yamazaki, editing by Louise Heavens)
Herro scores 24, Heat hit franchise playoff-record 23 3s to beat Boston and even series 1-1
Shohei Ohtani has 3 doubles, Landon Knack get 1st victory as Dodgers rout Nationals 11-2
Liverpool’s Premier League title hopes hit by 2-0 loss to Everton. Man United survives another scare
Cubs OF Cody Bellinger sidelined by two fractured ribs on his right side
Ex-minor league umpire sues MLB, says he was harassed by female ump, fired for being bisexual man
Connecticut Senate passes wide-ranging bill to regulate AI. But its fate remains uncertain
Biden pardons 11 people and shortens the sentences of 5 others convicted of non-violent drug crimes
Key moments in the Supreme Court’s latest abortion case that could change how women get care
Biden meets 4-year-old Abigail Edan, an American who was held hostage by Hamas
Hamas releases video showing well-known Israeli-American hostage
Relatives of those who died waiting for livers at now halted Houston transplant program seek answers
Jill Biden launches bike ride for wounded service members, stresses need to support vets
Gov. Gavin Newsom wants to let Arizona doctors provide abortions in California
More cows are being tested and tracked for bird flu. Here’s what that means
